Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-World Data

Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-World Data

The clinical benefits of nootropics in the treatment of cognitive decline has been either limited or controversial. This study aimed to observe the effectiveness of cholinesterase inhibitor (ChEI) and nootropics combination in the treatment of cognitive impairment in dementia. Data were based on ele...

Full description

Bibliographic Details
Main Authors:	Minjae Kang, Dan Bee Lee, Sungchan Kwon, Eun Lee, Woo Jung Kim
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Journal of Clinical Medicine
Subjects:	cholinesterase inhibitors nootropic agents dementia Alzheimer disease cognitive dysfunction mental status and dementia test
Online Access:	https://www.mdpi.com/2077-0383/11/16/4661

Similar Items

CHOLINESTERASE INHIBITORS IN THE TREATMENT OF DEMENTIA ALZHEIMER’S
by: Prameidya Primaniar S
Published: (2013-03-01)

Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer’s Disease and Other Dementias
by: Taim Muayqil, et al.
Published: (2012-11-01)

Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders
by: Giovanni B Frisoni, et al.
Published: (2021-08-01)

Persistence of Cholinesterase Inhibitor Treatment in Dementia: Insights from a Naturalistic Study
by: Javier Olazarán, et al.
Published: (2013-03-01)

Validation of the Argentine version of the Montreal Cognitive Assessment Test (MOCA): A screening tool for Mild Cognitive Impairment and Mild Dementia in Elderly
by: Cecilia M. Serrano, et al.
Published: (2020-06-01)

Systematic Review of Cholinesterase Inhibitors on Cognition and Behavioral Symptoms in Patients of Chinese Descent with Alzheimer’s Disease, Vascular Dementia, or Mixed Dementia
by: Ka-Chun Leung, et al.
Published: (2017-08-01)

Association of cognitive enhancers and incident seizure risk in dementia: a population-based study
by: Junghee Ha, et al.
Published: (2022-06-01)

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels
by: Marion Ortner, et al.
Published: (2020-05-01)

Thinking about cognition : concepts, targets and therapeutics /
by: Kruse, C. G. (Chris G.), 1952-
Published: (2006)

Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer’s disease dispensed by the Brazilian public health system – 2008 to 2014: a nation-wide analysis
by: Flávia Silva de Moraes, et al.

Ethical Underpinning and Implications of “Nootropic” Concept
by: Pranab Rudra
Published: (2018-12-01)

Anti-cholinergic drug burden in patients with dementia increases after hospital admission: a multicentre cross-sectional study
by: Annabelle Hook, et al.
Published: (2022-10-01)

Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
by: Dominik Glinz, et al.
Published: (2019-06-01)

Dementia patients have greater anti-cholinergic drug burden on discharge from hospital: A multicentre cross-sectional study
by: J. Randall, et al.
Published: (2021-04-01)

Dementia post-radiotherapy: improvement with acetylcholinesterase inhibitor A case report
by: Antonio Eduardo Damin, et al.

Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia
by: XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu
Published: (2023-11-01)

Alzheimer’s dementia: budget impact and cost-utility analysis of a combination treatment with a cholinesterase inhibitor and memantine in Switzerland
by: Alena M. Pfeil, et al.
Published: (2012-11-01)

Efficacy of pharmacological treatment of dementia
by: Leon Flicker
Published: (2002-04-01)

Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT
by: Sarah E Lamb, et al.
Published: (2018-05-01)

Positioning of nootropics in the national market
by: Al Nukari Abdulkarim, et al.
Published: (2018-10-01)

NOOTROPIC EFFECT OF COMPLEX PHYTOREMEDY «NOOPHYT» EXTRACT
by: N. Ts. Bazarova, et al.
Published: (2012-11-01)

Exploring Bhavana samskara using Tinospora cordifolia and Phyllanthus emblica combination for learning and memory in mice
by: Harshad Onkarrao Malve
Published: (2015-01-01)

Relative Efficacy of Piracetam, Modafinil and Citicoline on Cognitive Function in an Animal Model
by: Farrukh Ahmad, et al.
Published: (2017-11-01)

Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer’s Disease
by: Miguel Germán Borda, et al.
Published: (2019-04-01)

Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
by: Devika Jadhav, et al.
Published: (2024-01-01)

Flavonoid Derivatives as Potential Cholinesterase Inhibitors in Scopolamine-Induced Amnesic Mice: An In Vitro, In Vivo and Integrated Computational Approach
by: Fakhria A. Al-Joufi, et al.
Published: (2022-06-01)

Nootropic (medhya) effect of Bhāvita Śaṇkhapuṣpī tablets: A clinical appraisal
by: Hetal Amin, et al.
Published: (2014-01-01)

Huge Intracranial Meningioma Mimicking Alzheimer Dementia
by: Bohm Choi, et al.
Published: (2017-06-01)

Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)

POSSIBILITIES OF APPLICATION OF NOOTROPIC DRUGS IN TREATMENT OF EPILEPSY (LITERATURE REVIEW)
by: O. L. Badalyan, et al.
Published: (2016-05-01)

Assessment of the prevalence of nootropic drugs by elderly patients in geriatric practice
by: Emilia Główczewska-Siedlecka, et al.
Published: (2017-08-01)

Assessment of the prevalence of nootropic drugs by elderly patients in geriatric practice
by: Emilia Główczewska-Siedlecka, et al.
Published: (2017-08-01)

Prevalence of dementia in patients seen at a private hospital in the Southern Region of Brazil
by: Ricardo Krause Martinez de Souza, et al.
Published: (2019-10-01)

Treatment of vascular dementia Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
by: Sonia Maria Dozzi Brucki, et al.

The Enigma of Lewy Body Dementia: a Case Report
by: Ivana Orlović, et al.
Published: (2020-01-01)

Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: A longitudinal retrospective study
by: Magda Bucholc, et al.
Published: (2021-01-01)

Impact of a purported nootropic supplementation on measures of mood, stress, and marksmanship performance in U.S. active duty soldiers
by: Nicholas Barringer, et al.
Published: (2018-05-01)

Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM)
by: Aina Soler, et al.
Published: (2019-04-01)

Language impairment in the moderate stage of dementia due to Alzheimer's disease
by: Karin Zazo ORTIZ, et al.
Published: (2021-06-01)

QUANTITATIVE PHARMACO-EEG IN ACUTE CEREBRAL ISCHEMIA AND ITS DYNAMICS IN NOOTROPICS’APPLICATION CONDITIONS
by: E. V. Gantsgorn, et al.
Published: (2014-03-01)